Anti-inflammatory properties of high-density lipoprotein
高密度脂蛋白的抗炎特性
基本信息
- 批准号:8150953
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-20 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnalytical ChemistryAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApolipoproteins AAreaAtherosclerosisAwardBasic ScienceBiologicalBiomedical ResearchBudgetsCardiovascular DiseasesCell Culture TechniquesCellsCholesterolCollaborationsComplexCountryDataDevelopmentDevelopment PlansDiabetes MellitusDiseaseDoctor of PhilosophyEnvironmentEquilibriumFacultyFundingGenerationsGenomeGoalsGoatGrantHigh Density LipoproteinsHigh Pressure Liquid ChromatographyHumanIn VitroInflammationInflammatoryInstitutesInvestigationJournalsKnowledgeLaboratoriesLeadLearningLipidsLipoproteinsMedicineMentorsMentorshipMetabolismModificationMolecularObesityPaperPathway interactionsPeer ReviewPerformancePhasePlayPositioning AttributePostdoctoral FellowProbabilityProcessPropertyProtein ChemistryProteinsProteomicsPublishingRelative (related person)ResearchResearch PersonnelResearch TrainingRewardsRodent ModelRoleSamplingScienceScientistSelf AssessmentStructureTechniquesTestingTimeTrainingUnited StatesUnited States National Institutes of HealthUniversitiesVascular DiseasesWashingtonWorkcareercareer developmentcombatdiabeticdiabetic cardiomyopathyexperiencehuman tissuein vivoinhibitor/antagonistinstrumentationmedical schoolsmembermultidisciplinarynovel diagnosticsnovel therapeutic interventionoxidationoxidative damagepreventprofessorprogramsresearch studyskills
项目摘要
High-density lipoprotein (HDL) protects against atherosclerosis by removing excess cholesterol from arterial cells. HDL has also been proposed to function as an important Inhibitor of cellular inflammation and lipid oxidation in vivo. Moreover, inflammation has been proposed to convert HDL to a dysfunctional form that loses these cardioprotective effects and may even be pro-inflammatory. Two important pathways may Involve oxidative damage and changes in the relative balance of pro- and antioxidant proteins in HDL.
During the first two years of the award, the PI has completed a highly structured career development plan to prepare him for transition to a fully independent investigator. During this time, he has published five first author papers in peer-reviewed journals, that have directly addressed the hypotheses raised in the original proposal. Importantly, he has obtained strong preliminary data in diabetic humans that the proposed mechanisms for generation of dysfunctional HDL are pathophysiologically relevant. In collaboration with translational investigators at the University of Washington, the PI has laid the groundwork for developing a research program centered on understanding the role of HDL in diabetic cardiovascular disease. Importantly, the proposed studies are completely Independent of that of his mentor. He also has accepted a faculty position with the University of Washington and the Department of Medicine has assigned him independent laboratory space and an office at the newly established Diabetes and Obesity Center of Excellence.
During the next phase of the K99/R00 award, the PI will focus on two major goals: first, establishing a fully independent research program centered on diabetes and cardiovascular diseases. Second, obtaining NIH funding for his research studies. The long-term goal is to combat atherosclerosis by understanding the molecular mechanisms for generation of dysfunctional HDL in humans suffering from diabetes and other inflammatory conditions.
高密度脂蛋白(HDL)通过从动脉细胞中去除多余的胆固醇来预防动脉粥样硬化。还建议HDL充当体内细胞炎症和脂质氧化的重要抑制剂。此外,已经提出了炎症将HDL转换为失去这些心脏保护作用的功能失调的形式,甚至可能是促炎性的。两种重要的途径可能涉及HDL中促氧化和抗氧化剂蛋白的相对平衡的氧化损伤和变化。
在该奖项的前两年中,PI完成了一项高度结构化的职业发展计划,以准备过渡到完全独立的调查员。在此期间,他在同行评审期刊上发表了五篇第一篇作者论文,这些论文直接解决了原始提案中提出的假设。重要的是,他在糖尿病性人类中获得了强大的初步数据,即产生功能障碍HDL的提议的机制在病理生理上是相关的。与华盛顿大学的转化调查员合作,PI为制定了一项研究计划奠定了基础,该研究计划的重点是了解HDL在糖尿病心血管疾病中的作用。重要的是,拟议的研究完全独立于他的导师。他还接受了华盛顿大学的教职员工职位,医学系已将他分配给他独立的实验室空间,并在新成立的糖尿病和肥胖卓越中心的办公室任职。
在K99/R00奖的下一阶段,PI将重点关注两个主要目标:首先,建立一个以糖尿病和心血管疾病为中心的独立研究计划。其次,为他的研究获得NIH资金。长期的目标是通过了解患有糖尿病和其他炎症状况的人类产生功能失调的HDL的分子机制来对抗动脉粥样硬化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Baohai Shao其他文献
Baohai Shao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Baohai Shao', 18)}}的其他基金
Anti-inflammatory properties of high-density lipoprotein
高密度脂蛋白的抗炎特性
- 批准号:
8097031 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
Anti-inflammatory properties of high-density lipoprotein
高密度脂蛋白的抗炎特性
- 批准号:
8293138 - 财政年份:2010
- 资助金额:
$ 24.9万 - 项目类别:
Anti-inflammatory properties of high-density lipoprotein
高密度脂蛋白的抗炎特性
- 批准号:
7532353 - 财政年份:2008
- 资助金额:
$ 24.9万 - 项目类别:
Anti-inflammatory properties of high-density lipoprotein
高密度脂蛋白的抗炎特性
- 批准号:
7663157 - 财政年份:2008
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
脑觉醒神经机制的电分析化学基础研究
- 批准号:22374010
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
固态电分析化学对土壤有机质含量的快速解析及响应机理
- 批准号:42277017
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
固态电分析化学对土壤有机质含量的快速解析及响应机理
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
蛋白质调控细胞命运的电分析化学基础研究
- 批准号:22104140
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
环境分析化学
- 批准号:
- 批准年份:2021
- 资助金额:万元
- 项目类别:优秀青年科学基金项目
相似海外基金
Optical platform for functional longitudinal imaging of metabolite uptake in vivo
用于体内代谢物摄取功能纵向成像的光学平台
- 批准号:
10585764 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Determinants of age-induced hearing loss and reversal strategies
年龄引起的听力损失的决定因素和逆转策略
- 批准号:
10496280 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Elucidation of mitochondrial mechanisms critical to mediating PFAS neurotoxicity
阐明对介导 PFAS 神经毒性至关重要的线粒体机制
- 批准号:
10805097 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol
长期接触电子烟气溶胶中的金属混合物会产生神经毒性和神经退行性风险
- 批准号:
10883865 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别: